z6尊龙官方网站（深圳市医疗器械检测中心）是深圳市市场监督管理局直属事业单位，是我市唯一一家法定的药品、医疗器械、化妆品专业检验和科研机构。

        z6尊龙官方网站（原深圳市药品检验所），由深圳市人民政府于1982年7月批准成立，1986年正式开展工作。2003年增设“深圳市医疗器械检测中心”；2015年更名为“z6尊龙官方网站”。先后获批国家港澳地区中成药注册检验机构、国家口岸药品检验机构、国家化妆品注册和备案检验机构、国家进口药材口岸检验机构、国家医疗器械监督检验机构、国家医疗器械抽检承检复检机构、医疗器械注册检验机构等资质及国家博士后科研工作站、院士工作站。拥有国内首家世界卫生组织药品质量控制预认证（以下简称“WHO-PQ”）（理化+微生物）实验室和国内唯一联合国药品检测全球长期合作实验室。建成粤港澳大湾区规模最大生物医药安全评价实验室和3个国家药监局重点实验室，全方位搭建国际、国家等技术平台30余个。经过多年发展，软硬件条件、综合实力位居全国药检系统前列。

        Shenzhen Institute for Drug Control (SZIDC), also known as Shenzhen Testing Center of Medical Devices (STCMD), is a public institution directly affiliated to Shenzhen Administration for Market Regulation, and the only legal organization for professional testing and scientific research of drugs, medical devices and cosmetics in Shenzhen.

        The SZIDC was established with the approval the People’s Government of Shenzhen Municipality in July 1982 and was officially put into operation in 1986. In 2003, Shenzhen Testing Center of Medical Devices (STCMD) was additionally opened. In 2015, the Chinese name of the Institute was changed. SZIDC has successively acquired qualifications such as the National Registration and Inspection Institution for Traditional Chinese Medicine in Hong Kong and Macao, the National Drug Inspection Institution for Ports, the National Registration and Record-filing Inspection Institution for Cosmetics, the National Port Inspection Institution for Imported Medicinal Materials, the National Supervision and Inspection Institution for Medical Devices, the National Sampling Inspection and Re-inspection Institution for Medical Devices, and the Medical Devices Registration and Inspection Institution as well as national post-doctoral research workstation and academician workstation. SZIDC possesses the China’s first domestic WHO Prequalified (WHO-PQ) Quality Control Laboratory for both Physicochemical and Microbiological testing and the first global drug testing laboratory of the United Nations Development Program (UNDP) for long-term cooperation. SZIDC has established the largest biopharmaceutical safety evalsuation laboratory in the Guangdong-Hong Kong-Macao Greater Bay Area, 3 key laboratories designated by the National Medical Products Administration, and more than 30 technical platforms at the international and national levels. After years of development, SZIDC’s hardware and software conditions, as well as comprehensive strength, rank among the top within China pharmaceutical inspection system.